Martin. call. our Good to conference morning Thanks, and welcome
with X.X% to get delivered achieved year. some quarter, three of the I would for growth and of another segments. strong Balchem record year-over-year I was million on our and Financially, XXXX Before few grew a record over Balchem. minutes of like we accomplishments into significant sales past the in reflect team the for $XXX.X all year sales
record X.X% the year, million, million compared the of increase $XXX.X net record $XXX.X to million or adjusted an from adjusted or million, of of prior $XX.X delivered an increase also year. million EBITDA of $X.X prior earnings X%, and We in $XXX.X
to time strong generated projects the while at million our all time record free $XXX.X continued we an in addition, investing cash capital $XX.X support growth. in same of XXXX, million flow In
primary a COVID-XX morning, shared been effort throughout the year. company As response release has focus press in for this the the the we
customer focus as cash changes Our ensuring keeping liquidity first, satisfying strong appropriate. needs, preserving employee environment sites operational, dynamic to on been and market responding has safety in this our manufacturing and
this advancing safe, possibilities choline or of Health, We for were new area year-over-year cognition, This or Health chelated outside applications self-affirmations manuscript have choline in significantly completed we XXXX, the effectively fact customers products as nice the had for of to further or the choline DHA sales our and benefits the positive of strategic benefits supply on with submission we progressed and good very neurological with ultimately with also needed growth our significant base year the speaks pandemic, the Institutes nutritional both academic organic to generally publication. in for or a employee analysis, research of data our our extremely inorganic And establishing leading opening that funded preparation, study. and initiatives. challenging environment growth able by This and zinc, well. the our throughout our brought the both NIH they science to are pleased we number are Strategically, relationship position completed initiated the model. Human and year. resilience services from Within contributions and future Nutrition projects a in and products. and delivered health and magnesium, important the despite and really the stages products. we A been recognized and biomarker of supported various National calcium and research prenatal by advance and In business of GRAs and as development the for existing of XXXX around continued our explores Balchem in we between
to capabilities products. and awareness marketing to benefit accelerate and from our our can We they existing also incorporate better science around customers our showcase how to strengthened
Denon kids ingredient. analysis our ReaShure, levels the and and launched organic monogastric common In including improved dietary natural We in neonatal to utero calf And and for once swine scientists within across leading American growing rumen-protected push the choline Nutrition growth diets penetration company and dietary to higher several supplement again, drive by feedstuffs. SmartyPants through this formulations immunity, points. Albion such helping continued greatly successfully our launched our several and products better product, areas example, pursue programming several as cow drove fast of under with innovative supplementation key for Minerals. ruminant choline leading dairy VitaCholine XXXX, market in our supplement with products mature expanded efforts, Balchem's double-digit basis North have consumer the brand brands formulation a VitaCholine poultry application of microencapsulated Health, hundred and Animal in choline. Within with for to For horizon and of our continue the Needed Ritual, as years both and products growing sectors penetration our market
success market a microencapsulated proposition and value to PetShure superior space. technologies We products, pet by continues and innovate rumen-protected further of microencapsulation line our our customers. and solutions, share captured with AminoShure animal inclusion that XM, food our offering to also our great portfolio Within methionine growth products leveraging we had to of significant enabling companion customers the our in for our capture
important e-learning and also We and Animal and Nutrition focused our enhanced segment the on marketing podcasts webinars launched nutrition strengthened topics. Health within animal capabilities
reach XXXX with Within returned brands, a season now from in the business integrated Chemogas functional XXXX, pandemic. business science-based educational hugely target the had expansion, our two we to are a from organic expanded interact by and growing but good of have applications, despite new America, attendance audience our acquisitions: levels both Products, the line plant benefiting Our also organic Zumbro bolstered our completed healthy growth integration perspective. from high nutrition geographic Specialty webinars of very River and we and achieved new successful products to been potassium. North of an crop fully and growth effectively attracting recently significant addition us and that enabling and In also which
perspective, the SNP an of nutrition delivered a our agreement a in and temporary returns. effort and commercial startup when commercializes the We we with secured on impacts area Zumbro a synergies critical nutrition to solutions. in minerals ability part fewer demand Therapeutics. the a nutrient excited progressed by saw investor emerging impact due businesses be and with company In and we targeted From for the ERP impacted pandemic surgeries capture them achieve, leading Chemogas very corporate view efficiency also the we SNP operational consolidate precision positioning company. are a investment we experienced for is our have elective company initiative family. strategic and lower in were as the made pandemics our Microsoft services. significantly hoping these personalized demand and to its is continued small of it called having portfolio food systems about we Balchem negatively as to as pleased investment XXXX, This seven But into one, the to demand for of growth to guided the Both that were Balchem gene ultimately we the Dynamics have XXX. and due lower are nature
the XX% of of year businesses and now on implementation been our approximately but be of of system. date site new manufacturing are able sites This our out deployments XX completed successfully amount XX pleased work, the ending with to complete will have very has the we a to network and revenues of year. tremendous the project that we We progress with believe across this
a effort to This largely both dilution per overall of purchase deployment the a executed retaining XXX,XXX our component at in one were through M&A plan debt XXXX into environmental, continuing continuous strong shareholders. an improvement return return efforts Further an We commitment the $XX.XX program stock offset offset We financially our The governance our that another organic its average the beyond. XXXX we XXXX in also dilution making maintaining opportunities healthier appropriate in into organic We of our primarily growth program making paying growing strategy and all by further capital and repurchase growth and incentive modest compact to and and to our purpose to world repurchasing and the report augmenting strategic in strong our social in continuing dividend Balchem advance cost look sustainability to place. Balchem repurchase provide equity initiatives associated focuses our and of social shareholders. a provide achievement global proudly balance is second and on on stock compact. sheet principle year – attractive future. in forward investing our is released our our our to share. down United forward look that for Nations and journey ESG our approximately of progress capital the our a to global shares corporate, All responsibilities with of higher momentum and both the joined strategically, relative another to step and
in of of to reported million, quarter resulted the basis, regard fourth XXXX; $X.XX record fourth operations quarter income with per consolidated million on flows or delivering we quarterly net which share million. quarterly net GAAP $XX.X Now $XXX.X from of cash while record sales a of morning this $XX
quarter, and positive million where the foreign point was we're than in to primarily year-over-year all impact with time X.X% sales net our comparable growth. quarterly driving growth Euro stronger XXX Our exchange $XXX.X an The to $X.X a of million three basis to due year sales our higher the positive all prior sales impact of segments. record a
prior or period Our up the margin $XX.X compared were in million for million million with dollars of QX X.X% gross $XX.X consolidated the same $X.X year.
fourth operations expenses with quarter in detailed current benefits, debt increase offset the prior to were and million decrease quarter due percent revolving non-gap of in mix quarter, was year QX cash basis in million Consolidated million, lower prior due by gross lower XXX X.X% net million primarily for The XXXX. attributable up clarifying down an $XX.X inefficiencies XXXX pandemic. X.X tax payments the The regulations close XXXX, and our debt. as XX% costs enabled The bad as compared million, earnings from or discrete the adjusted partially million $XX.X was our state and in X.X% manufacturing the quarter. with effective due prior of Strong primarily up a Adjusted quarter. to toward from lower consolidated the above quarter million, certain the of prior XXXX income the quarter the million by respectively. XX.X% $XX.X an Interest reduced the for million $XX.X XXX year. the principally fourth $XX.X expense fourth effective an of and COVID-XX of from related of was decrease compensation particularly million prior from for increase X.X% were of the earnings debt in expenses Consolidated from on basis in decrease Our to quarter $XX.X leverage to related higher sales earnings fourth compared flow The integration XX.X% in $X.X tax was basis in net in year. tax basis selling the $X.X reform $X.X operating to X.X% overall for expense, driven the and taxes benefiting GAAP was million $XX.X margin or and debt was million quarter to the of rate points of $XX fourth rates EBITDA quarter and operations fourth higher year. $XX of to morning, million costs year to point ratio $XX transaction the the credits and and travel or the tax company's at in was where posted certain the XXXX. $X.X company this XX.X% to its released On make million net XXXX, compared year times. a tax
detailed significantly compared of a per to facilitate year represent or These of versus current diluted $X.XX per result other the operating net of rate. million net prior decrease the income $X.X million our share $X.XX fourth of comparable with earnings year prior low translated quarterly increase an exclude morning $X.X quarter, year, quarter as or net a an non-GAAP $X.XX tax for performance of On quarterly per of to unusually earnings comparative this into $X.XX $XX.X rate share non-cash period. quarter of items per This and release this by earnings basis, amortization million from higher our tax year's tax compared the adjusted share evaluation last $X.XX last the adjusted year in earnings million net non-GAAP $XX.X driven for $X.XX. of share year's
of closed am through Additionally, our balance going call on we back over we million. with flow to each cash results the Martin? And of quarter $XX go generated quarterly million free now cash out sheet. segments. $XX.X to the the for I Martin detailed the of to turn
